Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease
about
Action plans for COPD: strategies to manage exacerbations and improve outcomesExpert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of ChinaUsefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomized clinical trial with C-reactive protein testing in the intervention group.PURLs: Should you consider antibiotics for exacerbations of mild COPD?Diagnostic aid to rule out pneumonia in adults with cough and feeling of fever. A validation study in the primary care setting.Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbationsRandomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Update in chronic obstructive pulmonary disease 2012.Antimicrobial treatment of non-cystic fibrosis bronchiectasis.Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?Bacteria in COPD; their potential role and treatment.The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease.Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice.The Clinical Management Of Lower Respiratory Tract Infections.An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD.General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled triaMulticentre investigation of pathogenic bacteria and antibiotic resistance genes in Chinese patients with acute exacerbation of chronic obstructive pulmonary disease.Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.Antibiotics for COPD exacerbations.Appropriate antibiotic management of bacterial lower respiratory tract infectionsBetter Tests Also in Primary Care
P2860
Q26744059-1678CC67-9BBD-44F4-B5D1-81F4E3968745Q33559286-F6B3B89D-C1CA-4F4C-A9F9-95282ECF5F8FQ33593199-15FBD176-28F4-46DE-BD5F-3B96C4FD3FE8Q33703968-A502012E-7614-408D-A34F-F898C11CCB8DQ34514266-89759F58-C624-4E8D-9145-6E059C1ACCD0Q34514304-128AEFFA-9769-46D6-A5D8-406D69008D5CQ34656522-301AA76B-F36D-45C0-A5BB-77154C0F2A33Q34799593-3500E4F8-44F0-416A-AAC7-6E8B1A1378DCQ35149431-BBED425F-45D5-4C80-AA96-6270FBD1795DQ35161572-8904EE92-E29D-470A-8B1D-3B7948B8B8A1Q36526951-171030E9-8A68-4B9F-B103-0565C8853C72Q37177278-830233BE-BF56-4207-97F3-A22F027E8BECQ38118392-AFCE801E-10DF-4FE9-97B3-BB92FA50A0B1Q38243206-636B37FE-DB93-41AF-AAC2-4D6BF33A2840Q38667550-97F04FF4-A3CB-480E-A9B5-4A44E88A37CBQ38846409-DB7EC780-BE33-4BBB-B3C4-F52455DEC124Q39200222-449A796A-EBF1-43B2-A0D5-9756DBD4DAC1Q39370816-6FC7F064-2415-467C-AEF1-CF6DEA2C1E5DQ40260675-0B8D71E0-538C-43D0-8577-DF4DFE75EA3CQ40785029-758A2B7E-33FB-4614-B06F-EE44790FC2C7Q41028419-B9E622EA-BC99-4142-8608-24FA09E7ADD6Q42172274-56B7D3D5-D92C-4B6B-8415-05B54891D3F4Q46703864-8FDF94A6-A44E-4CF5-9038-FB75E43D339BQ47127548-F902A972-349E-4CE0-A439-36FC47B5D334Q55022514-5FCFCAE1-7112-41EC-9BB4-C94D20027D54Q55262081-379E8F7F-95D4-4C0F-8810-4F83D9C4E495Q56942464-A2747736-6ABC-4FE9-BE42-2FD2E0549977Q57612623-EAE7B7BA-D3C5-4B6D-88AC-7843C5B01EB3
P2860
Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease
description
im August 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 August 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2012
@uk
name
Efficacy of Antibiotic Therapy ...... Obstructive Pulmonary Disease
@en
Efficacy of Antibiotic Therapy ...... Obstructive Pulmonary Disease
@nl
type
label
Efficacy of Antibiotic Therapy ...... Obstructive Pulmonary Disease
@en
Efficacy of Antibiotic Therapy ...... Obstructive Pulmonary Disease
@nl
prefLabel
Efficacy of Antibiotic Therapy ...... Obstructive Pulmonary Disease
@en
Efficacy of Antibiotic Therapy ...... Obstructive Pulmonary Disease
@nl
P2860
P50
P1476
Efficacy of antibiotic therapy ...... obstructive pulmonary disease
@en
P2093
Carolina Bayona
Silvia Hernández
P2860
P304
P356
10.1164/RCCM.201206-0996OC
P407
P577
2012-08-23T00:00:00Z